https://scholars.lib.ntu.edu.tw/handle/123456789/616506
標題: | Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study | 作者: | CHIH-HSIN YANG Reckamp K.L. Kim Y.-C. Novello S. Smit E.F. Lee J.-S. Su W.-C. Akerley W.L. Blakely C.M. Groen H.J.M. Bazhenova L. Carcereny Costa E. Chiari R. Hsia T.-C. Golsorkhi T. Despain D. Shih D. Popat S. Wakelee H. |
公開日期: | 2021 | 出版社: | Elsevier Inc. | 卷: | 2 | 期: | 2 | 來源出版物: | JTO Clinical and Research Reports | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102035727&doi=10.1016%2fj.jtocrr.2020.100114&partnerID=40&md5=5781ed8741870310590f9aadccd8fc46 https://scholars.lib.ntu.edu.tw/handle/123456789/616506 |
ISSN: | 2666-3643 | DOI: | 10.1016/j.jtocrr.2020.100114 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。